- Details
- Description
Packaging Size:
1 × 1’s
Strength:
40 mg/4 mL
Composition:
Nivolumab INN
Treatment:
Anti-Cancer / Oncology
Form:
Injection
Brand:
NIVAMO
Quantity Unit:
Vial
Manufacturer:
Ziska Pharmaceuticals Limited
NIVAMO (Nivolumab INN) is an injectable monoclonal antibody and immune checkpoint inhibitor that blocks the PD-1 receptor, helping the immune system recognize and attack cancer cells. It is used in the treatment of several cancers, including certain lung, kidney, melanoma, head and neck, and other solid tumors, depending on the specific indication. NIVAMO is administered by intravenous infusion under medical supervision. The listed pack size is 1 × 1's.
